Healthcare Advisory

The depth and breadth of our healthcare experience make pH suited to advise healthcare companies throughout their product life cycle, regardless of the stage of their development or geographic region. We excel at looking beyond the immediate opportunity to unlock value for our clients through:

• Proactive and Comprehensive Approach – Strategic initiative that drives value beyond the immediate transaction
• Broad Network – Deep C-suite and board relationships with major strategics in each vertical
• Limited Clients – Ensures each pH client receives consistent attention

We combine senior investment bankers with experienced sector executives to drive successful transactions that focus on shareholder value regardless of time or form of consideration. Our bankers and executives deliver deep sector expertise in therapeutics, medical devices, digital health, HCIT, tools, diagnostics, labs and payors and providers.

As a partner-owned investment bank, we can focus on working closely with management teams to clearly understand:

• Each Product offerings’ unique benefit
• The Products “fit” within the current and future competitive landscape
• How client’s “solutions” affect all stakeholders in the marketplace

Our Healthcare partners have collectively closed over $20B in strategic advisory transactions, raised more than $5B in capital for our clients, and have a track record of generating highly favorable outcomes.